Anheuser-Busch InBev Valuation
Is ANB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ANB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ANB * (MX$970) is trading below our estimate of fair value (MX$1611.32)
Significantly Below Fair Value: ANB * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ANB *?
Other financial metrics that can be useful for relative valuation.
What is ANB *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$119.04b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.3x |
Enterprise Value/EBITDA | 10.7x |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does ANB *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 23.2x | ||
FEMSA UBD Fomento Económico Mexicano. de | 26.6x | 14.5% | Mex$660.2b |
AC * Arca Continental. de | 16.3x | 8.0% | Mex$285.0b |
BIMBO A Grupo Bimbo. de | 22x | 19.3% | Mex$302.1b |
CUERVO * Becle. de | 27.9x | 15.9% | Mex$125.6b |
ANB * Anheuser-Busch InBev | 22.3x | 13.9% | Mex$111.3b |
Price-To-Earnings vs Peers: ANB * is good value based on its Price-To-Earnings Ratio (22.3x) compared to the peer average (23.2x).
Price to Earnings Ratio vs Industry
How does ANB *'s PE Ratio compare vs other companies in the Global Beverage Industry?
Price-To-Earnings vs Industry: ANB * is expensive based on its Price-To-Earnings Ratio (22.3x) compared to the Global Beverage industry average (19.5x).
Price to Earnings Ratio vs Fair Ratio
What is ANB *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 22.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ANB *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$1,233.40 0% | 9.9% | Mex$1,544.91 | Mex$1,022.25 | n/a | 24 |
Apr ’25 | n/a | Mex$1,198.78 0% | 10.1% | Mex$1,532.98 | Mex$983.66 | n/a | 23 |
Mar ’25 | Mex$1,029.11 | Mex$1,202.66 +16.9% | 10.6% | Mex$1,563.70 | Mex$989.24 | n/a | 24 |
Feb ’25 | Mex$1,050.00 | Mex$1,217.36 +15.9% | 10.1% | Mex$1,543.07 | Mex$1,001.09 | n/a | 25 |
Jan ’25 | n/a | Mex$1,177.78 0% | 10.8% | Mex$1,520.82 | Mex$911.62 | n/a | 25 |
Dec ’24 | Mex$988.30 | Mex$1,195.84 +21.0% | 11.1% | Mex$1,551.23 | Mex$929.84 | n/a | 25 |
Nov ’24 | n/a | Mex$1,212.32 0% | 10.9% | Mex$1,595.91 | Mex$917.30 | n/a | 26 |
Oct ’24 | n/a | Mex$1,217.54 0% | 10.8% | Mex$1,584.11 | Mex$959.02 | n/a | 28 |
Sep ’24 | n/a | Mex$1,173.15 0% | 11.3% | Mex$1,523.12 | Mex$922.10 | n/a | 28 |
Aug ’24 | n/a | Mex$1,176.16 0% | 11.6% | Mex$1,520.03 | Mex$925.94 | n/a | 28 |
Jul ’24 | Mex$964.34 | Mex$1,188.65 +23.3% | 10.7% | Mex$1,542.63 | Mex$983.60 | n/a | 26 |
Jun ’24 | n/a | Mex$1,234.48 0% | 12.7% | Mex$1,594.59 | Mex$765.94 | n/a | 27 |
May ’24 | n/a | Mex$1,259.66 0% | 13.0% | Mex$1,612.03 | Mex$776.34 | n/a | 27 |
Apr ’24 | n/a | Mex$1,239.44 0% | 13.6% | Mex$1,626.78 | Mex$783.45 | n/a | 26 |
Mar ’24 | n/a | Mex$1,239.51 0% | 14.0% | Mex$1,711.12 | Mex$783.89 | Mex$1,029.11 | 28 |
Feb ’24 | n/a | Mex$1,271.50 0% | 13.9% | Mex$1,760.09 | Mex$806.33 | Mex$1,050.00 | 28 |
Jan ’24 | n/a | Mex$1,265.68 0% | 12.6% | Mex$1,566.65 | Mex$843.85 | n/a | 28 |
Dec ’23 | Mex$1,083.00 | Mex$1,242.10 +14.7% | 14.3% | Mex$1,615.67 | Mex$829.48 | Mex$988.30 | 29 |
Nov ’23 | n/a | Mex$1,244.68 0% | 16.2% | Mex$1,663.26 | Mex$843.05 | n/a | 28 |
Oct ’23 | n/a | Mex$1,313.98 0% | 16.1% | Mex$1,702.56 | Mex$862.97 | n/a | 28 |
Sep ’23 | n/a | Mex$1,326.18 0% | 15.4% | Mex$1,702.57 | Mex$888.20 | n/a | 28 |
Aug ’23 | n/a | Mex$1,341.57 0% | 15.2% | Mex$1,718.42 | Mex$896.47 | n/a | 28 |
Jul ’23 | n/a | Mex$1,380.70 0% | 15.9% | Mex$1,808.50 | Mex$904.86 | Mex$964.34 | 28 |
Jun ’23 | Mex$1,118.20 | Mex$1,346.47 +20.4% | 15.7% | Mex$1,770.10 | Mex$894.36 | n/a | 28 |
May ’23 | n/a | Mex$1,405.20 0% | 14.7% | Mex$1,833.46 | Mex$966.45 | n/a | 28 |
Apr ’23 | Mex$1,352.00 | Mex$1,418.84 +4.9% | 15.9% | Mex$1,832.52 | Mex$945.16 | n/a | 28 |
Analyst Forecast: Target price is less than 20% higher than the current share price.